We are live on ! Find out more
GCM

Geneva Capital Management Portfolio holdings

AUM $4.36B
1-Year Est. Return 17.81%
This Fund
S&P 500
This Quarter Est. Return
+32.58%
1 Year Est. Return
+17.81%
3 Year Est. Return
+59.44%
5 Year Est. Return
+75.65%
10 Year Est. Return
–
AUM
$4.62B
AUM Growth
+$1.1B
Cap. Flow
+$70.8M
Cap. Flow %
1.53%
Top 10 Hldgs %
22.6%
Holding
123
New
3
Increased
67
Reduced
50
Closed
3

Top Buys

Rank Stock Value
1
WDFC icon
WD-40
WDFC
+$18.9M
2
AXON
Axon Enterprise
AXON
+$17.8M
3
ESE icon
ESCO Technologies
ESE
+$12M
4
PLMR icon
Palomar
PLMR
+$11.6M
5
BCPC
Balchem Corp
BCPC
+$10.5M

Top Sells

Rank Stock Value
1
PAYC icon
Paycom
PAYC
+$31.2M
2
MASI
Masimo
MASI
+$25M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$17.8M
4
SXT icon
Sensient Technologies
SXT
+$15.3M
5
MCHP icon
Microchip Technology
MCHP
+$8.38M

Sector Composition

Rank Sector Weight
1 Technology 31.5%
2 Industrials 21.87%
3 Healthcare 19.11%
4 Consumer Discretionary 8.67%
5 Financials 6.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMAT icon
76
LeMaitre Vascular
LMAT
$1.86B
$23.5M 0.51%
891,892
+22,551
+3% +$590K
SSNC icon
77
SS&C Technologies
SSNC
$18.6B
$23.1M 0.5%
409,805
-4,771
-1% -$260K
TCBI icon
78
Texas Capital Bancshares
TCBI
$4.32B
$22.9M 0.5%
740,822
+24,830
+3% +$695K
LOPE icon
79
Grand Canyon Education
LOPE
$3.98B
$22.6M 0.49%
250,073
-3,799
-1% -$338K
FTDR icon
80
Frontdoor
FTDR
$6.26B
$22.4M 0.49%
506,270
+92,300
+22% +$3.77M
AXON
81
Axon Enterprise
AXON
$46.4B
$21.6M 0.47%
+220,073
New +$17.8M
CMD
82
DELISTED
Cantel Medical Corporation
CMD
$21.4M 0.46%
482,794
+17,086
+4% +$637K
ALGN icon
83
Align Technology
ALGN
$12.3B
$21.2M 0.46%
77,163
-2,217
-3% -$499K
AX icon
84
Axos Financial
AX
$5.68B
$21M 0.45%
951,583
+26,932
+3% +$548K
IT icon
85
Gartner
IT
$11.7B
$20.8M 0.45%
171,245
-1,828
-1% -$211K
SBNY
86
DELISTED
Signature Bank
SBNY
$20.1M 0.44%
188,180
-3,578
-2% -$352K
RGEN icon
87
Repligen
RGEN
$9.25B
$20M 0.43%
162,104
+78,502
+94% +$9.24M
WSO icon
88
Watsco Inc
WSO
$13.6B
$19.4M 0.42%
109,450
-1,536
-1% -$254K
COO icon
89
Cooper Companies
COO
$14.5B
$19.2M 0.42%
271,444
-4,756
-2% -$353K
RJF icon
90
Raymond James Financial
RJF
$34B
$18.5M 0.4%
403,649
-8,613
-2% -$388K
ULTA icon
91
Ulta Beauty
ULTA
$24.3B
$18M 0.39%
88,609
-1,601
-2% -$344K
MCHP icon
92
Microchip Technology
MCHP
$46B
$16.9M 0.37%
321,208
-186,312
-37% -$8.38M
TRMB icon
93
Trimble
TRMB
$13.9B
$16.1M 0.35%
372,667
-79,527
-18% -$2.98M
PLMR icon
94
Palomar
PLMR
$3.45B
$15.1M 0.33%
+175,583
New +$11.6M
CGNX icon
95
Cognex
CGNX
$11.3B
$14.1M 0.31%
236,182
-1,340
-0.6% -$72.8K
JBHT icon
96
JB Hunt Transport Services
JBHT
$25.2B
$13.2M 0.29%
110,091
-2,642
-2% -$285K
HAS icon
97
Hasbro
HAS
$13.2B
$12.8M 0.28%
171,173
-35,297
-17% -$2.55M
FBIN icon
98
Fortune Brands Innovations
FBIN
$6.06B
$10.7M 0.23%
195,200
-4,717
-2% -$219K
CRI icon
99
Carter's
CRI
$1.47B
$10.3M 0.22%
127,701
-3,047
-2% -$243K
VAR
100
DELISTED
Varian Medical Systems, Inc.
VAR
$8.08M 0.17%
65,935
-35,938
-35% -$4.16M
1 2 3
4
5

Similar funds

SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
EQF
Evergreen Quality Fund Grand Cayman, Cayman Islands $4.37B AUM 119.42% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
FIS
Fundsmith Investment Services Grande Riviere Noire, Mauritius $4.41B AUM 6.68% 1-Year Est. Return
CFO
Callan Family Office Radnor, Pennsylvania $4.41B AUM 26.21% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

Geneva Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Geneva Capital Management held 123 positions worth $4.62B, up 31% from $3.52B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2020: portfolio turnover was 4.9%. Geneva Capital Management opened 3 new positions and exited 3, leaving the 123-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Industrials and Healthcare.

  • Geneva Capital Management's largest Q2 2020 buy was Axon Enterprise: 220,073 shares worth $21.6M.
  • Geneva Capital Management added most to WD-40 in Q2 2020, an estimated $18.9M increase.
  • Geneva Capital Management's biggest Q2 2020 reduction was Paycom, cutting an estimated $31.2M.
  • Geneva Capital Management fully exited Ligand Pharmaceuticals in Q2 2020, selling an estimated $17.8M.
  • Geneva Capital Management's ten largest holdings make up 23% of its $4.62B portfolio in Q2 2020.
  • Geneva Capital Management opened 3 new positions and closed 3 in Q2 2020.
  • Geneva Capital Management's portfolio value rose 31% quarter-over-quarter to $4.62B.

Based on Geneva Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.